References
- Manji HK , QuirozJA, SpornJ et al. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol. Psychiatry 53(8) , 707–742 (2003).
- Quiroz JA , GouldTD, ManjiHK. Molecular effects of lithium. Mol. Interv.4(5) , 259–272 (2004).
- Boer U , EglinsJ, KrauseD, SchnellS, SchoflC, KnepelW. Enhancement by lithium of cAMP-induced CRE/CREB-directed gene transcription conferred by TORC on the CREB basic leucine zipper domain. Biochem. J.408(1) , 69–77 (2007).
- Heinrich A , BoerU, TzvetkovM, OetjenE, KnepelW. Stimulation by lithium of the interaction between the transcription factor CREB and its co-activator TORC. Biosci. Rep.29(2) , 77–87 (2009).
- Heinrich A , der Heyde AS, Boer U, Phu DT, Tzvetkov M, Oetjen E. Lithium enhances CRTC oligomer formation and the interaction between the CREB coactivators CRTC and CBP – implications for CREB-dependent gene transcription. Cell. Signal.25(1) , 113–125 (2013).
- Mamdani F , AldaM, GrofP, YoungLT, RouleauG, TureckiG. Lithium response and genetic variation in the CREB family of genes. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(4) , 500–504 (2008).
References
- Manji HK , QuirozJA, PayneJL et al. The underlying neurobiology of bipolar disorder. World Psychiatry 2(3) , 136–146 (2003).
- Young W . Review of lithium effects on brain and blood. Cell Transplant.18(9) , 951–975 (2009).
- Manji HK , ChenG. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers. Mol. Psychiatry7(Suppl. 1) , S46–S56 (2002).
- Moretti M , ValvassoriSS, SteckertAV et al. Tamoxifen effects on respiratory chain complexes and creatine kinase activities in an animal model of mania. Pharmacol. Biochem. Behav. 98(2) , 304–310.
- Cechinel-Recco K , ValvassoriSS, VarelaRB et al. Lithium and tamoxifen modulate cellular plasticity cascades in animal model of mania. J. Psychopharmacol. 26(12) , 1594–1604 (2012).
References
- Malhotra AK , ZhangJP, LenczT. Pharmacogenetics in psychiatry: translating research into clinical practice. Mol. Psychiatry17 , 760–769 (2012).
- Porcelli S , FabbriC, SpinaE et al. Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism. Expert Opin. Drug Metab. Toxicol. 7 , 1101–1115 (2011).
- Jaquenoud Sirot E , van der Velden JW, Rentsch K et al. Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance. Drug Saf.29 , 735–768 (2006).
- Baumann P , ZullinoDF, EapCB. Enantiomers‘ potential in psychopharmacology – a critical analysis with special emphasis on the antidepressant escitalopram. Eur. Neuropsychopharmacol.12 , 433–444 (2002).
- Jaquenoud Sirot E , HarenbergS, VandelP et al. Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depression. J. Clin. Psychopharmacol. 32 , 622–629 (2012).
References
- Mann JJ . Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology21(Suppl. 2) , 99S–105S (1999).
- Pineyro G , BlierP. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol. Rev.51(3) , 533–591 (1999).
- Parsey RV , OlvetDM, OquendoMA, HuangYY, OgdenRT, MannJJ. Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology31(8) , 1745–1749 (2006).
- Zhao X , HuangY, LiJ et al. Association between the 5-HT1A receptor gene polymorphism (rs6295) and antidepressants: a meta-analysis. Int. Clin. Psychopharmacol. 27(6) , 314–320 (2012).
- Higgins JP , ThompsonSG, DeeksJJ, AltmanDG. Measuring inconsistency in meta-analyses. BMJ327(7414) , 557–560 (2003).
- Kato M , SerrettiA. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol. Psychiatry15(5) , 473–500 (2010).